IntegriChain provides a SaaS commercialization and revenue optimization platform for biopharma manufacturers, integrating data, software, and managed services to manage market access, payer contracting, patient services, and distribution analytics. Its ICyte platform unifies key commercial, financial, and operational data and is used by more than 250 manufacturers. Founded in 2005 and headquartered in Philadelphia, the company is privately held and backed by Nordic Capital.